Oracle stock will remain under pressure until it provides tangible evidence that its spending is paying off.

Investors continue to fret whether the company has bitten off more than it can chew with its AI-spending commitments.

Upon validation, device developers will also have the opportunity to showcase their connected care technologies in the Oracle ...

Historical data suggests that ORCL is particularly susceptible to abrupt and steep declines, making it a high-volatility play for investors during periods of ...

Oppenheimer believes that a sharp recent pullback in Oracle has created an attractive risk-reward balance for investors. The ...

Oracle (ORCL) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Oracle shares were down 4.5% on Monday, after The Information reported that the cloud firm’s Stargate joint venture with OpenAI and SoftBank floundered after its flashy announcement at the White House ...

Oracle Database 26ai embeds AI capabilities directly into production databases, enabling enterprises to deploy AI securely ...

Atlanta expands cloud partnership to streamline permitting and licensing as population growth drives demand for services.

DTE Energy reports better-than-expected quarterly earnings.

Oracle Health has launched a device validation program aimed at standardizing how medical devices connect to health systems and electronic health records. The company introduced the Oracle Health ...